Concord Medical Co., Ltd. (TPEX:6518)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.20
0.00 (0.00%)
Sep 8, 2026, 11:44 AM CST

Concord Medical Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
85.7967.3649.5742.7450.6634.4
Depreciation & Amortization
80.2283.3584.5878.6175.9996.25
Other Amortization
1.591.611.630.820.430.34
Loss (Gain) From Sale of Assets
-0.14-0.07-0.15-0.41-1.69-9.16
Loss (Gain) From Sale of Investments
-24.54-8.8----
Provision & Write-off of Bad Debts
-0.130.031.020.17-0.69-1.84
Other Operating Activities
-4.540.793.35-5.333.913.63
Change in Accounts Receivable
-6.689.354.459.48-2.726.64
Change in Inventory
-8.290.2-1.432.023.18-6.53
Change in Accounts Payable
3.88-4.784.32-15.1417.830.67
Change in Other Net Operating Assets
4.18.191.480.267.6613.02
Operating Cash Flow
131.26157.24148.83113.23154.56137.42
Operating Cash Flow Growth
-29.69%5.65%31.45%-26.74%12.47%63.47%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.62-33.82-74.72-88.18-37.46-21.8
Sale of Property, Plant & Equipment
0.851.333.164.4719.8430.88
Cash Acquisitions
1.281.83----
Sale (Purchase) of Intangibles
-1.47-1.47-1.65-1.51-0.6124.19
Sale (Purchase) of Real Estate
-3.71-3.71----
Investment in Securities
-13-32.7-22.5-109-97.23-
Other Investing Activities
-23.991.923.386.145.15-0.1
Investing Cash Flow
-42.67-66.62-92.33-188.08-110.3133.17

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-25.5----
Long-Term Debt Issued
---35--
Total Debt Issued
-1425.5-35--
Long-Term Debt Repaid
--64-24.69-22.11-19.58-120.69
Lease Payments
-29.77-27.31-24.69-22.11-19.58-19.75
Total Debt Repaid
-65.29-64-24.69-22.11-19.58-120.69
Net Debt Issued (Repaid)
-79.29-38.5-24.6912.89-19.58-120.69
Issuance of Common Stock
-----100
Common Dividends Paid
-50-36.67-33.33-33.33-16.67-10
Other Financing Activities
-0.02-0.02--40.3540.11-0.53
Financing Cash Flow
-129.31-75.19-58.02-60.83.87-31.22

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-40.7215.43-1.51-135.6548.11139.38

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
128.64123.4274.1225.05117.1115.63
Free Cash Flow Growth
14.03%66.52%195.91%-78.61%1.27%-
Free Cash Flow Margin
12.39%12.80%8.33%3.01%13.17%15.65%
Free Cash Flow Per Share
3.843.682.210.753.514.61
Levered Free Cash Flow
100.64104.9954.5916.19108.82121.36
Unlevered Free Cash Flow
103.16107.4256.8118.39111.01124.35
Free Cash Flow After Leases
98.8796.1149.432.9397.5295.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.413.543.553.523.514.79
Cash Income Tax Paid
15.2413.8310.116.69.54.59
Change in Working Capital
-6.9812.968.82-3.3925.9513.8